The Center for Genetics and Society brings social justice and human rights to the center of public and policy discussions about human genetics and assisted reproduction.

Featured

Biopolitical Times

"Golden mitochondria" by National Institutes of Health
(NIH) is licensed under CC BY-NC 2.0

Last week, researchers at the UK’s Newcastle Fertility Centre published the findings of their years-long experiment with “mitochondrial donation” techniques, also known as three-person IVF. In two papers published in the New England Journal of Medicine, they reported on eight children born from the technique. The children range in age from five months to over two years old. One pregnancy is ongoing. While...

Press Statement

The Center for Genetics and Society, a project of the Tides Center, has been awarded $751,000 by the Mellon Foundation to support activities that establish a more complete understanding of the histories and legacies of eugenics. This generous grant will...

Biopolitical Times

Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several...

Aggregated News

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer...

Biopolitical Times

Mike Pennington / Dolly the sheep, National
Museums of Scotland, Edinburgh
 / CC BY-SA 2.0

The first mammal cloned from an...

Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several...

News

In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...

A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.

In a surprising reversal, Sarepta on Monday said it will pause all shipments...

One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening. 

The man died...

This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...

Video

Reproduction and Family Formation: The State and the Market
Use Gene Editing to Make Better Babies | Debate | Intelligence Squared U.S.
The 'Perfect' Baby?: The Dangers of Gene Editing in Assisted Reproduction